An Add-On Treatment for Moderate COPD with Squill-Oxymel (a Traditional Formulation from Drimia maritima (L.) Stearn ): A Pilot Randomized Triple-Blinded Placebo-Controlled Clinical Trial.

Maryam Mohammadi-Araghi Alireza Eslaminejad Hossein Karegar-Borzi Saeideh Mazloumzadeh Fatemeh Nejatbakhsh

Published in: Evidence-based complementary and alternative medicine : eCAM (2022)

The findings of this research provide preliminary evidence for the effectiveness and safety of Squill-Oxymel as an add-on therapy in individuals with mild COPD.

Keyphrases

placebo controlled
chronic obstructive pulmonary disease
clinical trial
double blind
study protocol
lung function
phase ii
phase iii
randomized controlled trial
high intensity
open label
stem cells
squamous cell carcinoma
phase ii study
replacement therapy